MedTrace Logo

Impact of Incomplete Endometrial Ablation

NCT06122363 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2025-06-12

No results posted yet for this study

Summary

The aim of the proposed protocol is to study the impact of incomplete endometrial ablation on the PBAC score, reintervention, satisfaction, controlled bleeding and dysmenorrhea at 24 months after Novasure endometrial ablation, in women with heavy menstrual bleeding treated at Máxima Medical Centre Veldhoven, in The Netherlands.

Conditions

  • Heavy Menstrual Bleeding

Interventions

DEVICE

hysteroscopy

uterine hysteroscopy right after Novasure endometrial ablation

Sponsors & Collaborators

  • Maxima Medical Center

    lead OTHER

Principal Investigators

  • Marlies M.Y. Bongers, PhD, MD · Maxima Medical Center

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2025-08-01
Completion
2025-12-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06122363 on ClinicalTrials.gov